483 related articles for article (PubMed ID: 25838393)
1. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.
Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ
Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156
[TBL] [Abstract][Full Text] [Related]
3. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
4. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer.
Augoff K; Hryniewicz-Jankowska A; Tabola R
Cancer Lett; 2015 Mar; 358(1):1-7. PubMed ID: 25528630
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lactate dehydrogenase a by 14-3-3ζ leads to increased glycolysis critical for breast cancer initiation and progression.
Chang CC; Zhang C; Zhang Q; Sahin O; Wang H; Xu J; Xiao Y; Zhang J; Rehman SK; Li P; Hung MC; Behbod F; Yu D
Oncotarget; 2016 Jun; 7(23):35270-83. PubMed ID: 27150057
[TBL] [Abstract][Full Text] [Related]
7. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
Chen CY; Feng Y; Chen JY; Deng H
Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of targeting cancer metabolism for cancer therapy.
Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
[TBL] [Abstract][Full Text] [Related]
10. Isoflurane promotes glucose metabolism through up-regulation of
Guo NL; Zhang JX; Wu JP; Xu YH
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28951521
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of LDHA expression in cancer cells leads to redox-dependent alterations in cytoskeletal structure and cell migration.
Arseneault R; Chien A; Newington JT; Rappon T; Harris R; Cumming RC
Cancer Lett; 2013 Sep; 338(2):255-66. PubMed ID: 23583676
[TBL] [Abstract][Full Text] [Related]
12. Targeting glucose metabolism in chondrosarcoma cells enhances the sensitivity to doxorubicin through the inhibition of lactate dehydrogenase-A.
Hua G; Liu Y; Li X; Xu P; Luo Y
Oncol Rep; 2014 Jun; 31(6):2727-34. PubMed ID: 24789077
[TBL] [Abstract][Full Text] [Related]
13. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
Qiu H; Jackson AL; Kilgore JE; Zhong Y; Chan LL; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2015 Mar; 6(9):6915-30. PubMed ID: 25762632
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response.
Gill KS; Fernandes P; O'Donovan TR; McKenna SL; Doddakula KK; Power DG; Soden DM; Forde PF
Biochim Biophys Acta; 2016 Aug; 1866(1):87-105. PubMed ID: 27373814
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
Zhang SL; He Y; Tam KY
Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
[TBL] [Abstract][Full Text] [Related]
17. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.
Le A; Cooper CR; Gouw AM; Dinavahi R; Maitra A; Deck LM; Royer RE; Vander Jagt DL; Semenza GL; Dang CV
Proc Natl Acad Sci U S A; 2010 Feb; 107(5):2037-42. PubMed ID: 20133848
[TBL] [Abstract][Full Text] [Related]
19. Metabolic phenotype of bladder cancer.
Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
[TBL] [Abstract][Full Text] [Related]
20. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
